Vithalbhai Dhaduk
2021
In 2021, Vithalbhai Dhaduk earned a total compensation of $48.2K as Chairman and former Interim Chief Executive Officer at MARIZYME.
Compensation breakdown
| Option Awards | $48,191 |
|---|---|
| Total | $48,191 |
Dhaduk received $48.2K in option awards, accounting for 100% of the total pay in 2021.
Rankings
In 2021, Vithalbhai Dhaduk's compensation ranked 12,314th out of 12,415 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,314 out of 12,415 | 1st |
Division Manufacturing | 5,455 out of 5,501 | 1st |
Major group Chemicals And Allied Products | 2,361 out of 2,371 | 0th |
Industry group Drugs | 2,082 out of 2,092 | 1st |
Industry Pharmaceutical Preparations | 1,536 out of 1,542 | 0th |
Source: SEC filing on November 10, 2022.
Dhaduk's colleagues
We found seven more compensation records of executives who worked with Vithalbhai Dhaduk at MARIZYME in 2021.
2021
Steven Brooks
MARIZYME
Chief Medical Officer
2021
Catherine Pachuk
MARIZYME
Chief Scientific Officer
2021
Amy Chandler
MARIZYME
Former Executive Vice President of Regulatory Affairs and Quality Management Systems
2021
James Sapirstein
MARIZYME
Chief Executive Officer
2021
Neil Campbell
MARIZYME
Chief Executive Officer
2021
Roger Schaller
MARIZYME
former Executive Vice President of Commercial Operations
2021
David Barthel
MARIZYME